Results 1 to 10 of about 40,571 (305)

Post-COVID-19 Maxillary Bony Sequestration: A Case Report on Mucormycosis Challenges. [PDF]

Clin Case Rep
ABSTRACT COVID‐19‐associated mucormycosis (CAM) is a severe opportunistic infection, typically affecting immunocompromised patients. Maxillary bony sequestration as a delayed complication in immunocompetent individuals is rare, highlighting diagnostic and therapeutic challenges.
Mohebbi S, Zabihidan M, Omidvari A, Abrishami M.   +3 more
europepmc   +2 more sources

Global Epidemiology of Mucormycosis

Journal of Fungi, 2019
Mucormycosis is an angio-invasive fungal infection, associated with high morbidity and mortality. A change in the epidemiology of mucormycosis has been observed in recent years with the rise in incidence, new causative agents and susceptible population ...
Hariprasath Prakash, Arunaloke Chakrabarti   +1 more
doaj   +2 more sources

CT Findings for Differentiating Pulmonary Mucormycosis From Invasive Pulmonary Aspergillosis, Prior to Invasive Procedure Such as a Biopsy or Surgery: A 22-Year Single-Center Experience. [PDF]

Mycoses
ABSTRACT Objectives Computed tomography (CT) plays a critical role in the early detection and diagnosis of pulmonary invasive mould infection. This study aimed to compare the CT findings of proven invasive pulmonary aspergillosis (IPA) and proven pulmonary mucormycosis (PM) and develop a clinical scoring system based on CT features to differentiate PM ...
Jang HM, Kim MY, Lim SY, Chang EJ, Bae S, Jung J, Kim MJ, Chong YP, Choi SH, Lee SO, Kim YS, Kim SH.   +11 more
europepmc   +2 more sources

Risk factors for COVID-19-associated mucormycosis (CAM): A case-control study [PDF]

Journal of Family Medicine and Primary Care
Introduction: Mucormycosis, a rare but serious fungal infection, surged during the second wave of the COVID-19 pandemic. Despite various proposed causative factors, published data are limited.
Akkilagunta Sujiv, N. R. Aiswarya Lakshmi, Pradeep Ramrao Deshmukh, Jaya Prasad Tripathy, Mubashshera F. Khan, Victoria Thomas   +5 more
doaj   +2 more sources

Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]

Current Medical Mycology, 2023
Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman, Jayaraj Athimanjeri Thiruvengadam, Abinaya Ravichandran, Santhi Thoppappatty Sengottaiyan   +3 more
doaj   +1 more source

Rise of Mucormycosis during the COVID-19 Pandemic and the Challenges Faced [PDF]

Current Medical Mycology, 2023
Mucormycosis (previously called zygomycosis) is a diverse group of increasingly recognized and frequently fatal mycotic diseases caused by members of the class zygomycetes. Mucormycosis is around 80 times more common in India, compared to other developed
Malavika Kottarathil, Thayanidhi Premamalini, Sathyamurthy P, Anupma Kindo   +3 more
doaj   +1 more source

Mucormycosis

Infectious Disease Clinics of North America, 2021
Mucormycosis is a rare but aggressive fungal disease that mainly affects patients with poorly controlled diabetes mellitus and those who are severely immunocompromised, including patients with hematological malignancies and solid organ transplant recipients. Early recognition of infection is critical for treatment success, followed by prompt initiation
Julie M, Steinbrink, Marisa H, Miceli
  +8 more sources

Mucormycosis and COVID-19: A systemic review

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
COVID-19 presents severely in persons with immunocompromised states such as diabetes mellitus. Steroids are used in the management of COVID-19.
Ankit Kaushik, Anamika Jaiswal, Hari S Pandey, Paramjeet Singh   +3 more
doaj   +1 more source

Mucormycosis in 2023: an update on pathogenesis and management

Frontiers in Cellular and Infection Microbiology, 2023
Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the Mucorales family, with Rhizopus, Mucor, and Lichtheimia, accounting for > 90% of all cases.
Abdullah Alqarihi, D. Kontoyiannis, Ashraf S. Ibrahim   +2 more
semanticscholar   +1 more source

When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis

Journal of Fungi, 2021
Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and outcome of such patients are not well described.
Teny M. John, C. Jacob, D. Kontoyiannis
semanticscholar   +1 more source